Previous 10 | Next 10 |
24/7 Market News news releases related 24/7 Market News news releases and 24/7 Market News press releases from 09/14/23 10:05:32 on US and Canada Markets.
2023-09-14 10:05:32 ET DENVER, Colo., Sept 14, 2023 ( www.247marketnews.com)- News First Wave BioPharma Announces Exclusive Global License Agreement for Capeserod from Sanofi – First Wave BioPharma (NASDAQ: FWBI) is trading at $0.88, up $0.45 (+103.33%), on 64...
2023-09-14 10:05:32 ET DENVER, Colo., Sept 14, 2023 ( www.247marketnews.com)- News First Wave BioPharma Announces Exclusive Global License Agreement for Capeserod from Sanofi – First Wave BioPharma (NASDAQ: FWBI) is trading at $0.88, up $0.45 (+103.33%), on 64...
2023-09-14 09:19:38 ET DENVER, Colo., Sept 14, 2023 ( www.247marketnews.com )- The following five dividend paying companies hit their 52-week highs in the past month. This list is by no means comprehensive. After hitting a new 52-week high of $165.8499, Walmart Inc. (NYSE:WMT) i...
2023-09-14 09:07:26 ET (24/7 MARKET NEWS) – First Wave BioPharma, Inc. (NASDAQ:FWBI) stated, this morning, that it signed an agreement to license Sanofi’s (NASDAQ:SNY) selective 5-HT4 receptor partial agonist, Capeserod, which First Wave will repurpose and develop for gastroin...
2023-09-14 09:07:26 ET (24/7 MARKET NEWS) – First Wave BioPharma, Inc. (NASDAQ:FWBI) stated, this morning, that it signed an agreement to license Sanofi’s (NASDAQ:SNY) selective 5-HT4 receptor partial agonist, Capeserod, which First Wave will repurpose and develop for gastroin...
2023-09-13 10:18:38 ET DENVER, Colo., Sept 13, 2023 ( www.247marketnews.com)- News Rocket Pharmaceuticals Reaches FDA Alignment on Pivotal Phase 2 Trial Design for RP-A501 in Danon Disease AND Rocket Pharmaceuticals Announces Pricing of Public Offering of Common Stock ...
2023-09-13 10:18:38 ET DENVER, Colo., Sept 13, 2023 ( www.247marketnews.com)- News Rocket Pharmaceuticals Reaches FDA Alignment on Pivotal Phase 2 Trial Design for RP-A501 in Danon Disease AND Rocket Pharmaceuticals Announces Pricing of Public Offering of Common Stock ...
2023-09-13 10:18:38 ET DENVER, Colo., Sept 13, 2023 ( www.247marketnews.com)- News Rocket Pharmaceuticals Reaches FDA Alignment on Pivotal Phase 2 Trial Design for RP-A501 in Danon Disease AND Rocket Pharmaceuticals Announces Pricing of Public Offering of Common Stock ...
2023-09-13 09:14:10 ET (24/7 MARKET NEWS) – Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) stated, after yesterday’s market close, that it reached alignment with the Food and Drug Administration (FDA) on the global Phase 2 pivotal trial of RP-A501 for Danon Disease, a uniformly fa...
2023-09-13 07:57:58 ET (24/7 MARKET NEWS) – Mainz Biomed N.V. (NASDAQ:MYNZ) reported, this morning, positive topline results from its ColoFuture study, a multi-center international clinical trial assessing the potential to integrate a portfolio of novel gene expression (mRNA) biomark...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
18.48%Change Percent:
Procore Technologies Inc. Company Name:
PCOR Stock Symbol:
NYSE Market:
procore.com Website: